Carlos Garcia, MD
Nuclear Medicine · San Juan, PRNPI 1912984667
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Revance Therapeutics, Inc. at 29.9% of the total. 2025 is the largest year on record at $498, 3.1 times the $161 reported in 2019. Among nuclear medicine clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $40.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$288
- Viatris Specialty LLC$98
- Johnson And Johnson International$96
- Lantheus Medical Imaging, Inc.$90
- Abbott$89
- Genentech USA, Inc.$71
- plus $232 from 8 others
What the payments were for
- Food & beverage$964100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 2 | $288 |
| Viatris Specialty LLC | 4 | $98 |
| Johnson And Johnson International | 2 | $96 |
| Lantheus Medical Imaging, Inc. | 2 | $90 |
| Abbott | 1 | $89 |
| Genentech USA, Inc. | 3 | $71 |
| Boston Scientific | 2 | $56 |
| Boehringer Ingelheim | 2 | $49 |
| PBG Puerto Rico LLC | 1 | $28 |
| Grifols USA, LLC | 1 | $25 |
| Lilly USA, LLC | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| Mylan LLC | 1 | $16 |
| Chiesi USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$964 in reported general payments places this provider in the 90th percentile of 20 nuclear medicine providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SyringeEvolocumab | 13 | $7,428 |
| Methylprednisolone | 14 | $119 |
Paid to pharmacies, not to this prescriber.
Other nuclear medicine in San Juan
- Irma Molina-VicentySan Juan$305
- Roberto BordewykSan Juan$185
- Rosa Orsini ChevereSan Juan$146
- Eduardo Pascual-FerrerSan Juan$131
- Juan Negron-RiveraSan Juan$125
- Jose Morales MoraleSan Juan$52
- Sandra Gracia LopezCaguas$1K
- Ricardo Santiago MontalvoAguadilla$831
- Carlos JimenezRio Piedras$767
- Elba Orduna AcumManati$741
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.